Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The co... Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis.The company's primary sources of revenues include its sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.3694 | 29.3174603175 | 1.26 | 1.75 | 1.26 | 969136 | 1.56912594 | CS |
| 4 | 0.5894 | 56.6730769231 | 1.04 | 1.75 | 1.02 | 432775 | 1.41922303 | CS |
| 12 | 0.7194 | 79.0549450549 | 0.91 | 1.75 | 0.9 | 240465 | 1.27582159 | CS |
| 26 | 0.4294 | 35.7833333333 | 1.2 | 1.75 | 0.8214 | 273846 | 1.18917622 | CS |
| 52 | 0.2594 | 18.9343065693 | 1.37 | 1.9 | 0.8214 | 307516 | 1.30557815 | CS |
| 156 | 0.6494 | 66.2653061224 | 0.98 | 3.55 | 0.7 | 828773 | 1.67735499 | CS |
| 260 | 1.4084 | 637.285067873 | 0.221 | 7.02 | 0.221 | 779718 | 2.08859804 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 0,7722 (-5,00%) | 886,12M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 28,10 (3,58%) | 56,37M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,10 (1,31%) | 44,78M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,1205 (-0,96%) | 38,66M |
| ETHU2x Ether ETF | US$ 8,635 (16,85%) | 27,16M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
